Jennifer Keiser

ORCID: 0000-0003-0290-3521
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Parasites and Host Interactions
  • Helminth infection and control
  • Parasite Biology and Host Interactions
  • Research on Leishmaniasis Studies
  • Malaria Research and Control
  • Parasitic Diseases Research and Treatment
  • Global Maternal and Child Health
  • Child Nutrition and Water Access
  • Parasitic Infections and Diagnostics
  • Mosquito-borne diseases and control
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Coccidia and coccidiosis research
  • Trypanosoma species research and implications
  • Pharmacological Effects and Toxicity Studies
  • Insect Pest Control Strategies
  • Metabolomics and Mass Spectrometry Studies
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Zoonotic diseases and public health
  • Gut microbiota and health
  • Trace Elements in Health
  • Drug-Induced Hepatotoxicity and Protection
  • Parasitic infections in humans and animals
  • Ferrocene Chemistry and Applications
  • Dermatological diseases and infestations

Swiss Tropical and Public Health Institute
2016-2025

University of Basel
2016-2025

University Hospital of Basel
2024

Swiss School of Public Health
2024

University of Ghana
2023

University of California, Berkeley
2022

Health Net
2015

Ministry of Health
2015

University of Health Sciences Vientiane
2015

National Institute of Public Health
2015

Japanese encephalitis (JE), a vector-borne viral disease, is endemic to large parts of Asia and the Pacific. An estimated 3 billion people are at risk, JE has recently spread new territories. Vaccination programs, increased living standards, mechanization agriculture key factors in decline incidence this disease Japan South Korea. However, transmission likely increase Bangladesh, Cambodia, Indonesia, Laos, Myanmar, North Korea, Pakistan because population growth, intensified rice farming,...

10.3201/eid1501.080311 article EN cc-by Emerging infectious diseases 2008-12-30
Wesley C. Van Voorhis John H. Adams Roberto Adelfio Vida Ahyong Myles H. Akabas and 95 more Pietro Alano Alday Aintzane Yesmalie Alemán Resto Aishah M. Alsibaee Ainhoa Alzualde Katherine T. Andrews Simon V. Avery Vicky M. Avery Lawrence Ayong Mark Baker Stephen Baker Choukri Ben Mamoun Sangeeta N. Bhatia Q. D. Bickle Lotfi Bounaadja Tana Bowling Jürgen Bosch Lauren Boucher Fabrice Fekam Boyom José Brea Marian Brennan Burton Audrey Conor R. Caffrey Grazia Camarda Manuela Carrasquilla Dee Carter María B. Cassera Ken Cheng Chindaudomsate Worathad Anthony J. Chubb Beatrice L. Colon Daisy D. Colón-López Yolanda Corbett Gregory J. Crowther Noemi Cowan Sarah D’Alessandro Na Le Dang Michael J. Delves Joseph L. DeRisi Alan Y. Du Sandra Duffy Shimaa Abd El‒Salam El‒Sayed Michael T. Ferdig José A. Fernández Robledo David A. Fidock Isabelle Florent Patrick Valère Tsouh Fokou Ani Galstian Francisco‐Javier Gamo Suzanne Gokool Ben Gold Todd R. Golub Gregory M. Goldgof Rajarshi Guha W. Armand Guiguemde Nil Gural R. Kiplin Guy Michael A. E. Hansen Kirsten K. Hanson Andrew Hemphill Rob Hooft van Huijsduijnen Takaaki Horii Paul Horrocks Tyler B. Hughes Christopher D. Huston Ikuo Igarashi Katrin Ingram-Sieber Maurice A. Itoe Ajit Jadhav Amornrat Naranuntarat Jensen Laran T. Jensen Rays H. Y. Jiang Annette Kaiser Jennifer Keiser Thomas J. Ketas Sébastien Kicka Sun‐Young Kim Kiaran Kirk Vidya P. Kumar Dennis E. Kyle María José Lafuente Scott M. Landfear Lee Nathan Sukjun Lee Adele M. Lehane Fengwu Li David Little Liqiong Liu Manuel Llinás Marı́a Isabel Loza Michael A. Matthias Leonardo Lucantoni Isabelle S. Lucet Louis Maes Dalu Mancama

A major cause of the paucity new starting points for drug discovery is lack interaction between academia and industry. Much global resource in biology present universities, whereas focus medicinal chemistry still largely within Open source discovery, with sharing information, clearly a first step towards overcoming this gap. But interface could especially be bridged through scale-up open physical compounds, which would accelerate finding discovery. The Medicines Malaria Venture Box...

10.1371/journal.ppat.1005763 article EN public-domain PLoS Pathogens 2016-07-28

Malaria not only remains a leading cause of morbidity and mortality, but it also impedes socioeconomic development, particularly in sub-Saharan Africa. Rapid unprecedented urbanization, going hand-in-hand with often declining economies, might have profound implications for the epidemiology control malaria, as relative disease burden increases among urban dwellers. Reviewing literature using modeling approach, we find that entomologic inoculation rates cities range from 0 to 54 per year,...

10.4269/ajtmh.2004.71.118 article EN American Journal of Tropical Medicine and Hygiene 2004-08-01

Human-made ecologic transformations have occurred at an unprecedented rate over the past 50 years. Prominent among them are water resource development projects. An estimated 40,000 large dams and 800,000 small been built, 272 million hectares of land currently under irrigation worldwide. The establishment operation projects has had a history facilitating change in frequency transmission dynamics malaria, but analyses these environmental risk factors sparse. Here, we present comprehensive...

10.4269/ajtmh.2005.72.392 article EN American Journal of Tropical Medicine and Hygiene 2005-04-01

Background The treatment and control of schistosomiasis, an often neglected tropical disease that exacerbates poverty, depends on a single drug, praziquantel. large-scale use praziquantel might select for drug-resistant parasites, hence there is need to develop new antischistosomal compounds. Here, we report the antimalarial drug mefloquine possesses promising properties in mice. Methodology/Principal Findings A dose (200 or 400 mg/kg) administered orally mice infected with adult Schistosoma...

10.1371/journal.pntd.0000350 article EN cc-by PLoS neglected tropical diseases 2009-01-06
Coming Soon ...